Contains fulltext : 87304.pdf (publisher's version ) (Open Access)Prostate cancer (PCa) patients receive androgen-deprivation therapy (ADT) to reduce tumor burden. However, complete eradication of PCa is unusual, and recurrent disease is evident within approximately 2 years in high-risk patients. Clinical evidence suggests that combining ADT with radiotherapy improves local control and disease-free survival in these patients compared with radiotherapy alone. We investigated whether vascularization of androgen-sensitive PCa xenografts changed after ADT and whether such therapy affected radiation response. CWR22 xenografts received combinations of ADT by castration (CWR22-cas) and 15 Gy of single-dose irradiation. At a short...
Purpose: To evaluate the effect of whole pelvic radiotherapy (WPRT) in prostate cancer patients trea...
Contains fulltext : 170668.pdf (publisher's version ) (Open Access)Development of ...
Context: Androgen deprivation therapy (ADT) for prostate cancer (PCa) represents one of the most eff...
Prostate cancer (PCa) patients receive androgen-deprivation therapy (ADT) to reduce tumor burden. Ho...
Prostate cancer (PCa) patients receive androgen-deprivation therapy (ADT) to reduce tumor burden. Ho...
Prostate cancer (PCa) patients receive androgen-deprivation therapy (ADT) to reduce tumor burden. Ho...
AbstractProstate cancer (PCa) patients receive androgen-deprivation therapy (ADT) to reduce tumor bu...
Contains fulltext : 110167.pdf (publisher's version ) (Open Access)BACKGROUND: Rad...
Jason F Lester,1 Malcolm D Mason1,2 1Velindre Hospital, Whitchurch, 2School of Medicine, Cardiff Uni...
Item does not contain fulltextBACKGROUND AND PURPOSE: The shrinking effect of androgen deprivation t...
Purpose: Accurate prostate cancer (PCa) detection is essential for planning focal external beam radi...
Introduction: Neo-adjuvant androgen deprivation therapy prior to radiotherapy (RT) causes shrinkage ...
Objective: To assess quantitative variations in dispersion tensor magnetic character tractography in...
Background and purpose: In locally advanced prostate cancer (PC), androgen deprivation therapy (ADT)...
Contains fulltext : 81446.pdf (publisher's version ) (Closed access)BACKGROUND: Co...
Purpose: To evaluate the effect of whole pelvic radiotherapy (WPRT) in prostate cancer patients trea...
Contains fulltext : 170668.pdf (publisher's version ) (Open Access)Development of ...
Context: Androgen deprivation therapy (ADT) for prostate cancer (PCa) represents one of the most eff...
Prostate cancer (PCa) patients receive androgen-deprivation therapy (ADT) to reduce tumor burden. Ho...
Prostate cancer (PCa) patients receive androgen-deprivation therapy (ADT) to reduce tumor burden. Ho...
Prostate cancer (PCa) patients receive androgen-deprivation therapy (ADT) to reduce tumor burden. Ho...
AbstractProstate cancer (PCa) patients receive androgen-deprivation therapy (ADT) to reduce tumor bu...
Contains fulltext : 110167.pdf (publisher's version ) (Open Access)BACKGROUND: Rad...
Jason F Lester,1 Malcolm D Mason1,2 1Velindre Hospital, Whitchurch, 2School of Medicine, Cardiff Uni...
Item does not contain fulltextBACKGROUND AND PURPOSE: The shrinking effect of androgen deprivation t...
Purpose: Accurate prostate cancer (PCa) detection is essential for planning focal external beam radi...
Introduction: Neo-adjuvant androgen deprivation therapy prior to radiotherapy (RT) causes shrinkage ...
Objective: To assess quantitative variations in dispersion tensor magnetic character tractography in...
Background and purpose: In locally advanced prostate cancer (PC), androgen deprivation therapy (ADT)...
Contains fulltext : 81446.pdf (publisher's version ) (Closed access)BACKGROUND: Co...
Purpose: To evaluate the effect of whole pelvic radiotherapy (WPRT) in prostate cancer patients trea...
Contains fulltext : 170668.pdf (publisher's version ) (Open Access)Development of ...
Context: Androgen deprivation therapy (ADT) for prostate cancer (PCa) represents one of the most eff...